Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia

Cancer is the leading cause of death by disease in children. Most pediatric tumors differ from adult tumors in terms of biological and clinical characteristics. In children, the part of genetic determinism could be higher since the role of environmental factors may be less pronounced than in adults and that …

pediatric
cancer
  • 0 views
  • 05 Aug, 2020
Communication Memory of Cancer Diagnosis Within the Pediatric Triangle

Present project aims to investigate memories related to a cancer communication diagnosis in pediatric oncology. It evaluates possible common elements and specificity between family and healthcare staff.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Securing Access to Innovative Molecules in Oncology and Hematology for Children Adolescents and Young Adults

It involves collecting safety and efficacy data, under the actual conditions of use of medicines in children and adolescents, using a validated tool (VIGINOM) and relying on the network of Interregional pediatric oncology appeal organizations (OIR) identified by INCa since 2010 and responsible for the organization of Pluridisciplinary Pediatric Interregional …

pediatric tumor
leukemia
plexiform neurofibroma
pediatric
NTRK
  • 0 views
  • 05 Aug, 2020
Advanced Translational Research on Childhood Leukemia

Prognosis of children with leukemia, the most common pediatric cancer, has improved markedly. Yet, relapse still occurs in 15-40% of patients with a probability of survival of <50%, which is unlikely to be boosted by intensification of standard chemotherapy due to overwhelming toxicity.

  • 0 views
  • 05 Aug, 2020
Cancer Therapy Effects on the Heart

Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) is commonly given to treat pediatric cancer, and carries a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death.

cancer treatment
cancer
pediatric cancer
anthracyclines
childhood cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location